EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molecular engineering approaches to half-life extension of therapeutic biomolecules

Yuli Wang, Junliang Chang, Jinghui Liu

Frontiers in Pharmacology · 10.04.2026 · 17

DOI: 10.3389/fphar.2026.1778569 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 10.04.2026. Verfasst von Yuli Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Changchun Institute of Biological Products Co., Ltd, Changchun, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic biomolecules are widely used to treat various diseases, but their clinical efficacy is often limited by short in vivo half-lives due to rapid renal filtration, proteolytic degradation, and immune clearance. Short half-life leads to frequent dosing, fluctuation in blood drug concentration, and increased treatment costs, severely limiting clinical efficacy. To address these challenges, various half-life extension strategies have been developed, including chemical conjugation (e.g., PEGylation), physical delivery systems (e.g., microspheres), and genetic/fusion approaches. This review provides a comprehensive narrative analysis of molecular engineering methods, discussing the rational design to directly optimize the drug molecule itself or fuse it with long-acting carriers to significantly extend its circulation time. A systematic comparison of several approaches is presented to guide rational strategy selection. By synthesizing current knowledge and recent advances, this review serves as a practical resource for researchers and drug developers navigating half-life extension technologies.

Schlagwörter

Stichwörter der Autor:innen

fusion proteinslong-acting therapeutic biomoleculesmolecular engineeringpharmacokineticsunstructured polypeptides

Autor:innen und Institutionen

  • Changchun Institute of Biological Products Co., Ltd, Changchun, China.

Zitieren

APA

Wang, Y., Chang, J., & Liu, J. (2026). Molecular engineering approaches to half-life extension of therapeutic biomolecules. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1778569

Vancouver

Wang Y, Chang J, Liu J. Molecular engineering approaches to half-life extension of therapeutic biomolecules. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1778569

BibTeX
@article{Wang2026,
  author = {Wang, Yuli and Chang, Junliang and Liu, Jinghui},
  title = {Molecular engineering approaches to half-life extension of therapeutic biomolecules},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1778569}
}
Kostenlos starten →